ArticleFrontiers in transplantation2023

Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis.

Srilakshmi Atthota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.